Dr. Ralph Thomas McLaughlin Jr., MD

Dr. McLaughlin practices at MultiCare Yakima Memorial Hospital in Yakima, Washington, part of MultiCare Health System.

Dr. McLaughlin's NPI, 1477606556, was assigned on January 19, 2007. Dr. McLaughlin graduated from Creighton University School of Medicine in 1987. Dr. McLaughlin holds Washington license MD00031045.

Dr. McLaughlin's primary practice is MultiCare Yakima Memorial Hospital, at 2811 Tieton Drive, Yakima, WA 98902 in Yakima County. The practice phone is (509) 575-8000.

Dr. McLaughlin's primary practice is MultiCare Yakima Memorial Hospital in Yakima, Washington, part of MultiCare Health System. The medical group on file is MultiCare Yakima Memorial. Dmand AI also links Dr. McLaughlin to 1 more clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. McLaughlin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. McLaughlin is licensed in Washington.

CMS data shows 427 Medicare services from Dr. McLaughlin across 11 procedure codes in 2024, for 226 Medicare patients. Medicare paid $34,006 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 75 to 84, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 82, with 40% women.

In 2024, Dr. McLaughlin wrote 1,442 Medicare Part D claims for 215 patients. 86% of them were for generic drugs. CMS names the drug for 1,344 of them, across 30 drugs with 11 or more claims each, at $145,367 in total drug cost. In 2023, CMS named 1,091 claims across 25 drugs.

CMS Open Payments shows 110 general payments to Dr. McLaughlin from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Siemens Medical Solutions USA, Inc. paid the most, $1,810.

Dr. McLaughlin graduated from Creighton University School of Medicine in 1987.